Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB. Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 2008;22:531−45.10.2165/00023210-200822070-00001Search in Google Scholar PubMed
2. Parvizi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying-A link to the cerebellum. Brain 2001;124:1708–19.10.1093/brain/124.9.1708Search in Google Scholar PubMed
3. Gondimfde A, Thomas FP, Cruz-Flores S, Nasrallah HA, Selhorst JB. Pathological laughter and crying: a case series and proposal for a new classification. Ann Clin Psychiatry 2016;28:11−21.Search in Google Scholar
4. Black KJ. Pathological laughing and crying. Am J Psychiatry 1994;151:456.10.1176/ajp.151.3.456aSearch in Google Scholar PubMed
5. Pioro EP. Current concepts in the pharmacotherapy of pseudobulbar affect. Drugs 2011;71:1193−207.10.2165/11591450-000000000-00000Search in Google Scholar PubMed
6. Ferentinos P. Duloxetine for pathological laughing and crying. Int J Neuropsychopharmacol 2009;12:1429–30.10.1017/S1461145709990745Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston